机译:耐辐射的肿瘤起始细胞的选择性靶向
Department of Molecular and Cellular Biology Baylor College of Medicine,Houston, TX 77030-3498;
Department of Molecular and Cellular Biology Baylor College of Medicine,Houston, TX 77030-3498 Graduate Program in Translational Biology and Molecular Medicine, Baylor College of Medicine,Houston, TX 77030-3498;
Department of Molecular and Cellular Biology Baylor College of Medicine,Houston, TX 77030-3498;
akt and wnt signaling; DNA damage repair; p53 mouse model;
机译:1B50-1是针对复发性肿瘤细胞的单克隆抗体,通过与钙通道α2δ1亚基结合而靶向肝肿瘤引发细胞
机译:从表达IL13Rα2的神经胶质瘤中分离出的茎样肿瘤引发细胞被IL13-zetakine重定向的T细胞靶向并杀死
机译:鼠异种移植模型中对5T4抗原特异性靶向肾细胞癌肿瘤起始细胞的CD8 + T细胞克隆
机译:肿瘤引发细胞的差异蛋白质组分析
机译:通过代谢和表观遗传法规靶向肿瘤引发干细胞
机译:耐辐射的肿瘤起始细胞的选择性靶向
机译:耐辐射的肿瘤起始细胞的选择性靶向
机译:靶向肿瘤起始细胞用于治疗乳腺癌。